Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TDP-43 Pathology in Alzheimer’s Disease
Axel Meneses, Shunsuke Koga, Justin O’Leary, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 182

Showing 1-25 of 182 citing articles:

Emerging diagnostics and therapeutics for Alzheimer disease
Wade Self, David M. Holtzman
Nature Medicine (2023) Vol. 29, Iss. 9, pp. 2187-2199
Closed Access | Times Cited: 184
Frequency of LATE neuropathologic change across the spectrum of Alzheimer’s disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts
Peter T. Nelson, Carol Brayne, Margaret E. Flanagan, et al.
Acta Neuropathologica (2022) Vol. 144, Iss. 1, pp. 27-44
Open Access | Times Cited: 112
Mis-spliced transcripts generate de novo proteins in TDP-43–related ALS/FTD
Sahba Seddighi, Yue Qi, Anna‐Leigh Brown, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 734
Open Access | Times Cited: 74
Dynamic mapping of proteome trafficking within and between living cells by TransitID
Wei Qin, Joleen S. Cheah, Charles Xu, et al.
Cell (2023) Vol. 186, Iss. 15, pp. 3307-3324.e30
Open Access | Times Cited: 73
A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS–FTD
Katherine E. Irwin, Pei Jasin, Kerstin E. Braunstein, et al.
Nature Medicine (2024) Vol. 30, Iss. 2, pp. 382-393
Open Access | Times Cited: 62
Fluid biomarkers for amyotrophic lateral sclerosis: a review
Katherine E. Irwin, Udit Sheth, Philip C. Wong, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 28
RNA dysregulation in neurodegenerative diseases
Yini Li, Shuying Sun
The EMBO Journal (2025) Vol. 44, Iss. 3, pp. 613-638
Open Access | Times Cited: 3
Aberrant splicing in Huntington’s disease accompanies disrupted TDP-43 activity and altered m6A RNA modification
Thai B. Nguyen, Ricardo Miramontes, Carlos Chillón-Marinas, et al.
Nature Neuroscience (2025)
Open Access | Times Cited: 2
The Common Alzheimer's Disease Research Ontology (CADRO) for biomarker categorization
Amanda M. Leisgang Osse, Jefferson W. Kinney, Jeffrey L. Cummings
Alzheimer s & Dementia Translational Research & Clinical Interventions (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 2
Loss of Stathmin-2, a hallmark of TDP-43-associated ALS, causes motor neuropathy
Kelsey L. Krus, Amy Strickland, Yurie Yamada, et al.
Cell Reports (2022) Vol. 39, Iss. 13, pp. 111001-111001
Open Access | Times Cited: 60
Ginsenoside Rg1 in neurological diseases: From bench to bedside
Shaojie Yang, Jing-ji Wang, Ping Cheng, et al.
Acta Pharmacologica Sinica (2022) Vol. 44, Iss. 5, pp. 913-930
Open Access | Times Cited: 56
APOE4 exacerbates α-synuclein seeding activity and contributes to neurotoxicity in Alzheimer’s disease with Lewy body pathology
Yunjung Jin, Fuyao Li, Berkiye Sonoustoun, et al.
Acta Neuropathologica (2022) Vol. 143, Iss. 6, pp. 641-662
Open Access | Times Cited: 39
Mis-spliced transcripts generatede novoproteins in TDP-43-related ALS/FTD
Sahba Seddighi, Yue Qi, Anna‐Leigh Brown, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 36
A fluid biomarker reveals loss of TDP-43 splicing repression in pre-symptomatic ALS
Katherine E. Irwin, Pei Jasin, Kerstin E. Braunstein, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 35
Caenorhabditis elegans as a Model System to Study Human Neurodegenerative Disorders
Antonis Roussos, Katerina Kitopoulou, Fivos Borbolis, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 478-478
Open Access | Times Cited: 30
Cryptic exon detection and transcriptomic changes revealed in single-nuclei RNA sequencing of C9ORF72 patients spanning the ALS-FTD spectrum
Lauren M. Gittings, Eric Alsop, Jerry Antone, et al.
Acta Neuropathologica (2023) Vol. 146, Iss. 3, pp. 433-450
Open Access | Times Cited: 28
Presenilin-1 (PSEN1) Mutations: Clinical Phenotypes beyond Alzheimer’s Disease
YoungSoon Yang, Eva Bagyinszky, Seong Soo A. An
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8417-8417
Open Access | Times Cited: 27
CircTmeff1 Promotes Muscle Atrophy by Interacting with TDP‐43 and Encoding A Novel TMEFF1‐339aa Protein
Rui Chen, Tingting Yang, Bing Jin, et al.
Advanced Science (2023) Vol. 10, Iss. 17
Open Access | Times Cited: 25
Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception
Fabio Moda, Arianna Ciullini, Ilaria Linda Dellarole, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 10, pp. 255-255
Open Access | Times Cited: 24
Molecular mechanisms of phase separation and amyloidosis of ALS/FTD-linked FUS and TDP-43
Jianxing Song
Aging and Disease (2023) Vol. 15, Iss. 5, pp. 2084-2084
Open Access | Times Cited: 23
MRI biomarkers and neuropsychological assessments of hippocampal and parahippocampal regions affected by ALS: A systematic review
Sana Mohammadi, Sadegh Ghaderi, Farzad Fatehi
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 14
TDP-43 loss induces extensive cryptic polyadenylation in ALS/FTD
Sam Bryce-Smith, Anna‐Leigh Brown, Puja R. Mehta, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 13
A critical appraisal of blood-based biomarkers for Alzheimer’s disease
Simone Lista, Mark Mapstone, Filippo Caraci, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102290-102290
Closed Access | Times Cited: 12
TDP-43 dysregulation of polyadenylation site selection is a defining feature of RNA misprocessing in ALS/FTD and related disorders
Frederick J. Arnold, Ya Cui, Sebastian Michels, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 11
Phosphomimetic substitutions in TDP-43’s transiently α-helical region suppress phase separation
Haider Raza, Srinivasa R. Penumutchu, Solomiia Boyko, et al.
Biophysical Journal (2024) Vol. 123, Iss. 3, pp. 361-373
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top